Skip to main content
Clinical Trials/NCT04935086
NCT04935086
Completed
Not Applicable

Risk Factors for Predictors of Major Adverse Cardiovascular Events After Coronary Artery Bypass Using Radial Artery Grafts

Ruijin Hospital1 site in 1 country370 target enrollmentJune 30, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Ruijin Hospital
Enrollment
370
Locations
1
Primary Endpoint
7-day MACE-4
Status
Completed
Last Updated
last year

Overview

Brief Summary

As the secondary choice of artery grafts, radial artery is more and more used to achieve multiple arterial revascularization in CABG. Risk factors for predictors of major cardiovascular adverse events (MACE) after CABG using radial-artery grafts (RA-CABG), however, remain uncertain. This case-control study aims to identify the baseline predictors of MACE after RA-CABG.

We will collect the baseline characteristics and perioperative data of patients underwent RA-CABG from Jan. 2009 to Dec. 2019 in our single center. By reviewing the latest follow-up records, we will examine the correlation between the baseline characteristics and clinical outcomes (MACEs), then identify the independent risk factors for predictors of MACEs after RA-CABG.

Registry
clinicaltrials.gov
Start Date
June 30, 2021
End Date
November 30, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Qiang Zhao,MD

Professor and Director, Department of Cardiovascular Surgery, Vice President, Ruijin Hospital

Ruijin Hospital

Eligibility Criteria

Inclusion Criteria

  • Underwent CABG using at least a radial artery grafts from Jan.2009 to Dec.
  • with or without cardiopulmonary bypass , with or without concomitant procedure
  • Aged 18 and above at procedure
  • With any gender

Exclusion Criteria

  • With unavailable medical records

Outcomes

Primary Outcomes

7-day MACE-4

Time Frame: 7 days post-CABG

a composite of all-cause death, myocardial infraction, stroke and repeat revascularization

30-day MACE-4

Time Frame: 30 days post-CABG

a composite of all-cause death, myocardial infraction, stroke and repeat revascularization

1-year MACE-4

Time Frame: 1 year post-CABG

a composite of all-cause death, myocardial infraction, stroke and repeat revascularization

3-year MACE-4

Time Frame: 3 years post-CABG

a composite of all-cause death, myocardial infraction, stroke and repeat revascularization

Secondary Outcomes

  • MACE-3(7 days, 30 days, 1 year, and 3 years post-CABG)
  • All-cause death(7 days, 30 days, 1 year, and 3 years post-CABG)
  • CV-death(7 days, 30 days, 1 year, and 3 years post-CABG)
  • Myocardial infraction(7 days, 30 days, 1 year, and 3 years post-CABG)
  • Stroke(7 days, 30 days, 1 year, and 3 years post-CABG)
  • Repeat revascularization(7 days, 30 days, 1 year, and 3 years post-CABG)

Study Sites (1)

Loading locations...

Similar Trials